Baker Bros. Advisors »

Pharvaris N V shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.4M 375k 24.95

More positions owned by Baker Bros. Advisors

BeOne Medicines Sponsored Ads (ONC)
Incyte Corporation (INCY)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kymera Therapeutics (KYMR)
Kodiak Sciences (KOD)
Alkermes SHS (ALKS)
Abcellera Biologics (ABCL)
Edgewise Therapeutics (EWTX)
Kiniksa Pharmaceuticals International Ord Shs Cl A (KNSA)

View all positions for Baker Bros. Advisors

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Bain Capital Life Sciences Investors
Deerfield Management Company
Commodore Capital
Paradigm Biocapital Advisors
Novo A/S
Wellington Management Company
Cormorant Asset Management
Saturn V Capital Management
5AM Venture Management

View all funds holding Pharvaris N V